Clinical trialNCT06586957RecruitingPhase 1Interventional

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

SponsorNiKang Therapeutics, Inc.Enrollment150Advanced Endometrial CarcinomaAdvanced Gastric CarcinomaAdvanced Ovarian CarcinomaAdvanced Solid TumorCCNE1 AmplificationEndometrial Diseases+22 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Arkansas Medical School
Little Rock, Arkansas, United States
Michael Birrer, MD
Recruiting
University of California - Los Angeles
Los Angeles, California, United States
Gottfried Konecny, MD
Not, yet, recruiting
Ucsf
San Francisco, California, United States
Withdrawn
Scri at Healthone
Denver, Colorado, United States
Gerald Falchook, MD
Recruiting
Florida Cancer Specialists & Research Institute
Lake Mary, Florida, United States
Terminated
Adventhealth Cancer Institute
Orlando, Florida, United States
Guru Sonpavde, MD
Recruiting
Emory Winship Cancer Institute
Atlanta, Georgia, United States
Jennifer Scalici, MD
Recruiting
Augusta University
Augusta, Georgia, United States
Sharad Ghamande, MD
Not, yet, recruiting
University of Kansas
Fairway, Kansas, United States
Withdrawn
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Elizabeth LEE, MD
Recruiting
John Theurer Cancer Center at Hackensack Umc
Hackensack, New Jersey, United States
Martin Gutierrez, MD
Recruiting
Sidney Kimmell Cancer Center - Jefferson Health
Philadelphia, Pennsylvania, United States
Ida Micaily, MD
Recruiting
Upmc
Pittsburgh, Pennsylvania, United States
Withdrawn
Sarah Cannon Research Institute (scri)
Nashville, Tennessee, United States
Denise Yardley, MD
Recruiting
Next Oncology
Austin, Texas, United States
Sheena Sahota, MD
Recruiting
Ut Southwestern
Dallas, Texas, United States
David Miller, MD
Recruiting
Intermountain Health
Salt Lake City, Utah, United States
Caroline Nebhan, MD
Recruiting
University of Virginia
Charlottesville, Virginia, United States
Linda Duska, MD
Recruiting
Next Virginia
Fairfax, Virginia, United States
Alexander Spira, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

NKT3964 →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Sept 2024
Primary completion: 31 Jan 2029
Completion: 31 May 2029
Last update posted: 21 Apr 2026
Registered enrollment: 150
Registry id: NCT06586957

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.